Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Texas Instruments
TXN
|
$638M |
| 2 |
Broadcom
AVGO
|
$602M |
| 3 |
Tesla
TSLA
|
$492M |
| 4 |
American International
AIG
|
$465M |
| 5 |
Advanced Micro Devices
AMD
|
$421M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$426M |
| 2 |
Pinduoduo
PDD
|
$393M |
| 3 |
DexCom
DXCM
|
$367M |
| 4 |
Synopsys
SNPS
|
$350M |
| 5 |
Manhattan Associates
MANH
|
$290M |
Sector Composition
| 1 | Technology | 23.41% |
| 2 | Financials | 12.14% |
| 3 | Industrials | 11.35% |
| 4 | Healthcare | 11.18% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Lloyds Banking Group
LYG
$63.6B
| $70.7K | ﹤0.01% |
29,601
-173,710
| -85% | -$415K |
|
3602
Esperion Therapeutics
ESPR
$490M
| $69.3K | ﹤0.01% |
23,176
+681
| +3% | +$2.04K |
|
3603
ClearPoint Neuro
CLPT
$291M
| $69.3K | ﹤0.01% |
10,199
-1,335
| -12% | -$9.07K |
|
3604
Nautilus Biotechnolgy
NAUT
$80.7M
| $67.9K | ﹤0.01% |
22,712
+5,010
| +28% | +$15K |
|
3605
Erasca
ERAS
$406M
| $67.7K | ﹤0.01% |
31,798
+7,913
| +33% | +$16.9K |
|
3606
Compass Therapeutics
CMPX
$466M
| $67.4K | ﹤0.01% |
43,190
-22,906
| -35% | -$35.7K |
|
|
CGC
3607
Canopy Growth
CGC
$437M
| $65.9K | ﹤0.01% |
12,898
-379
| -3% | -$1.94K |
|
3608
Ring Energy
REI
$203M
| $65.8K | ﹤0.01% |
45,093
+10,846
| +32% | +$15.8K |
|
|
AUTL
3609
Autolus Therapeutics
AUTL
$383M
| $64.9K | ﹤0.01% |
10,078
-236
| -2% | -$1.52K |
|
|
JOAN
3610
DELISTED
JOANN, Inc. Common Stock
JOAN
| $63.6K | ﹤0.01% |
142,554
+1,564
| +1% | +$698 |
|
3611
Lineage Cell Therapeutics
LCTX
$281M
| $62K | ﹤0.01% |
56,879
-9,013
| -14% | -$9.82K |
|
3612
Expensify
EXFY
$174M
| $60.4K | ﹤0.01% |
24,437
-4,851
| -17% | -$12K |
|
3613
Ventyx Biosciences
VTYX
$184M
| $59.9K | ﹤0.01% |
24,258
-2,502
| -9% | -$6.18K |
|
3614
Humacyte
HUMA
$231M
| $59.9K | ﹤0.01% |
21,093
-2,551
| -11% | -$7.25K |
|
3615
Precigen
PGEN
$1.42B
| $59.6K | ﹤0.01% |
44,483
+12,959
| +41% | +$17.4K |
|
3616
Monte Rosa Therapeutics
GLUE
$309M
| $59.4K | ﹤0.01% |
+10,518
| New | +$59.4K |
|
3617
Actinium Pharmaceuticals
ATNM
$53.3M
| $58.7K | ﹤0.01% |
11,561
-22,049
| -66% | -$112K |
|
|
MOND
3618
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $55.8K | ﹤0.01% |
20,222
-2,159
| -10% | -$5.96K |
|
3619
Larimar Therapeutics
LRMR
$337M
| $55.8K | ﹤0.01% |
+12,258
| New | +$55.8K |
|
3620
DHI Group
DHX
$146M
| $54.9K | ﹤0.01% |
21,205
-16,168
| -43% | -$41.9K |
|
|
PPTA
3621
Perpetua Resources
PPTA
$2.07B
| $53.2K | ﹤0.01% |
16,769
-2,518
| -13% | -$7.98K |
|
|
IVAC
3622
DELISTED
Intevac Inc
IVAC
| $52.8K | ﹤0.01% |
+12,212
| New | +$52.8K |
|
3623
BioAtla
BCAB
$28.7M
| $52K | ﹤0.01% |
21,139
+3,282
| +18% | +$8.07K |
|
3624
ProKidney
PROK
$319M
| $51.5K | ﹤0.01% |
28,936
-11,710
| -29% | -$20.8K |
|
3625
Cadiz
CDZI
$290M
| $50.1K | ﹤0.01% |
17,885
-33,112
| -65% | -$92.7K |
|